Similar articles

• Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients.

  Suthanthiran M, Khanna A, Cukran D, Adhikarla R, Sharma VK, Singh T, August P. Suthanthiran M, et al. Kidney Int. 1998 Mar;53(3):639-44. doi: 10.1046/j.1523-1755.1998.00858.x. Kidney Int. 1998. PMID: 9507209
• Transforming growth factor beta and progression of renal disease.

  August P, Suthanthiran M. August P, et al. Kidney Int Suppl. 2003 Nov;(87):S99-104. doi: 10.1046/j.1523-1755.64.s87.15.x. Kidney Int Suppl. 2003. PMID: 14531781
• Transforming growth factor beta and excess burden of renal disease.

  August P, Sharma V, Ding R, Schwartz JE, Suthanthiran M. August P, et al. Trans Am Clin Climatol Assoc. 2009;120:61-72. Trans Am Clin Climatol Assoc. 2009. PMID: 19768163 Free PMC article.
• Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.

  August P, Leventhal B, Suthanthiran M. August P, et al. Curr Hypertens Rep. 2000 Apr;2(2):184-91. doi: 10.1007/s11906-000-0080-5. Curr Hypertens Rep. 2000. PMID: 10981147 Review.
• End-stage renal failure in African Americans: insights in kidney disease susceptibility.

  Freedman BI. Freedman BI. Nephrol Dial Transplant. 2002 Feb;17(2):198-200. doi: 10.1093/ndt/17.2.198. Nephrol Dial Transplant. 2002. PMID: 11812863 Review. No abstract available.